Previous 10 | Next 10 |
The ADRs of Danish biotech Orphazyme (NASDAQ:ORPH) is trading ~3% lower in the post-market on Wednesday after the company indicated that it is unlikely to receive the EU nod for its current marketing application for arimoclomol in Niemann-Pick disease type C (NPC). Regarding its rev...
Orphazyme (ORPH +16.7%) ADRs are trading sharply higher on Friday after the Danish biotech announced its plans to resubmit the U.S. marketing application for arimoclomol in H2 2022 targeting patients with Niemann-Pick disease type C (NPC). Last June, the FDA declined to approve the treatment ...
Gainers: Orphazyme ORPH +22%. Y-mAbs Therapeutics YMAB +11%. Oscar Health (NYSE:OSCR) +9%. Theravance Biopharma TBPH +9%. VistaGen Therapeutics (NASDAQ:VTGN) +8%. Losers: ProQR Therapeutics PRQR -72%. Senseonics SENS -19%. PetVivo P...
Buying Penny Stocks Today? Here’s What You Need to Know If you’re looking to find the best penny stocks to buy, there are plenty of options to choose from. But, to have the greatest chance of profitability, investors need to have a complete understanding of what is going o...
Kaival Brands Innovations (NASDAQ:KAVL) +20%. Codiak BioSciences (NASDAQ:CDAK) +16%. Castor Maritime (NASDAQ:CTRM) +14%. Zillow Z +13% on Q4 results. Orphazyme A/S (NASDAQ:ORPH) +14%. Zillow Group ZG +13% on Q4 results. Itau Unibanco ITUB +8% on Q4 results. Momentive...
Centogene N.V. (NASDAQ:CNTG) has appointed Kim Stratton as Chief Executive Officer, transitioning from her prior designation as Interim CEO. This nomination follows extension of medical leave by Dr. Andrin Oswald, the company’s Chief Executive Officer and Managing Director, who ha...
Trading Penny Stocks Today? Here’s What You Need to Know With another day of trading penny stocks and blue chips here, there’s a lot for investors to know. This is especially true following yesterday’s major stock market drop with the Dow posting an over 600 point l...
3 Penny Stocks For Your Watchlist Next Week As we get ready to enter another week of trading penny stocks, investors are excited about how November has gone so far. While it’s hard to say if the rest of the month will be bullish, we do know that there is a lot of bullish sentimen...
Orphazyme (NASDAQ:ORPH) shares surge more than 14% premarket after the company announces successful Type A meeting with the U.S. FDA for arimoclomol for the treatment of Niemann-Pick disease type C (NPC). NPC is a rare, genetic, progressively debilitating, and often fatal neurodegen...
FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 14, 2021 – USA News Group – Compared to the Dow Jones Industrial Average which has gained an impressive 10.6% through Q3 2021, and the S&P 500 and Nasdaq doing ev...
News, Short Squeeze, Breakout and More Instantly...
Orphazyme A/S Company Name:
ORPH Stock Symbol:
NASDAQ Market:
(NewsDirect) hVIVO PLC (AIM:HVO) chief executive Yamin 'Mo' Khan discusses the company's record-breaking financial results in 2023 in an interview with Proactive's Stephen Gunnion. hVIVO announced a 16% year-on-year growth in revenue, reaching £56 million, with an EBITDA margin i...
(NewsDirect) hVIVO chairman Cathal Friel joined Proactive's Stephen Gunnion to discuss the sale of shares in hVIVO PLC by directors, including himself. Friel explained his decision to sell a portion of his shares in hVIVO was to accommodate the high demand from major institutions whil...
(NewsDirect) hVIVO PLC (AIM:HVO) Chief Scientific Officer Andrew Catchpole speaks to Steve Darling from Proactive after the specialist contract research organisation announced it has secured a £6.3 million contract with a biotechnology client for the testing of their antiviral candid...